Fortis Group Advisors, LLC

Position in BMY — Bristol Myers Squibb Co

CIK 1815183 WESTWOOD, NJ

Position in BMY

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$28,810

-$1,515 QoQ

Shares Held

500

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#2,370

of 2,506 holders

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Fortis Group Advisors, LLC holds $10,238,680 across 11 Drug Manufacturers - General names. BMY ranks #8 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,471	$4,163,221
2	NVO	Novo Nordisk A S	72,916	$3,495,593
3	PFE	Pfizer Inc	62,653	$1,508,683
4	MRK	Merck & Co., Inc.	4,715	$605,877
5	AMGN	Amgen Inc	559	$202,424
6	JNJ	Johnson & Johnson	718	$182,350
7	GILD	Gilead Sciences, Inc.	246	$31,079
8	BMY	Bristol Myers Squibb Co This page	500	$28,810

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$28,810	500	0.0%	Shares	Sole	2026-07-24
2026-03-31	$30,325	500	0.0%	Shares	Sole	2026-05-08
2025-12-31	$26,970	500	0.0%	Shares	Sole	2026-02-06
2025-09-30	$22,550	500	0.0%	Shares	Sole	2025-11-07
2025-06-30	$23,145	500	0.0%	Shares	Sole	2025-08-08
2025-03-31	$30,495	500	0.0%	Shares	Sole	2025-05-02
2024-12-31	$28,280	500	0.0%	Shares	Sole	2025-01-31
2024-09-30	$25,870	500	0.0%	Shares	Sole	2024-10-21
2024-06-30	$20,765	500	0.0%	Shares	Sole	2024-07-30
2024-03-31	$27,115	500	-87.4%	Shares	Sole	2024-04-30
2023-12-31	$204,419	3,984	+14.4%	Shares	Sole	2024-03-04
2023-09-30	$202,211	3,484	-30.8%	Shares	Sole	2023-12-01
2020-09-30	$303,741	5,038	—	Shares	Sole	2020-11-17
No filing history on record for this holder in this stock.